American Academy of Dermatology Meeting

American Academy of Dermatology Meeting

March 08, 2017
1 min read
Save

Microneedling with tranexamic acid solution effectively treated rosacea

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ORLANDO, Fla. — Microneedling with tranexamic acid solution was an effective treatment for women with erythematotelangiectatic rosacea, according to late-breaking research presented at the American Academy of Dermatology Annual Meeting.

Fotini Bageorgou, MD, reported on a study of 20 women, aged between 27 and 65 years, with erythematotelangiectatic rosacea.

The patients were divided into two treatment groups. One group was treated only with tranexamic acid solution (Transamin inj/sol/500 mg/5 ml, Daiichi-Sankyo) infused wet dressing for 20 minutes, while the second group was treated with tranexamic acid solution topical application with simultaneous microneedling, followed by tranexamic aside solution-infused dressing therapy, every 15 days for four sessions.

Clinical photos, dermoscopy and the Investigator Global Assessment of Rosacea Severity Score (IGA-RSS) were used to measure efficacy.

All patients showed improvement by the end of the therapy, with significant improvement of 2 units of IGA-RSS for the cohort treated without microneedling and an improvement of 3 units IGA-RSS for the group treated with microneedling.

“According to our results, a new, really promising simple, safe and cheap treatment option targeting mainly to the vascular net and the erythema of rosacea is proposed,” the researchers wrote.  by Bruce Thiel

 

Reference:

Bageorgou F. F073 – Late-breaking Research Forum Procedural Dermatology. Presented at: American Academy of Dermatology Annual Meeting; March 3-7, Orlando.

Disclosure: Bageorgou reports no relevant conflicts of interest.